We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAC.WS
226
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
-50,000
Closed -$2.12K
ANAC
227
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
-200,000
Closed -$2.02M
ONEM
228
DELISTED
1Life Healthcare
ONEM
-4,725,000
Closed -$79M
LHCG
229
DELISTED
LHC Group LLC
LHCG
-689,000
Closed -$111M
LGAC
230
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
-300,000
Closed -$3.03M
LGACW
231
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
-60,000
Closed -$360
SCOB
232
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
-450,000
Closed -$4.56M
SCOBW
233
DELISTED
ScION Tech Growth II Warrants
SCOBW
-150,000
Closed -$540
GSQD
234
DELISTED
G Squared Ascend I Inc.
GSQD
-500,000
Closed -$5.05M
BACA.WS
235
DELISTED
Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50
BACA.WS
-1,237,500
Closed -$45.2K
CPARW
236
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
-150,780
Closed -$256
CPAR
237
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
-835,638
Closed -$8.42M
SVFA
238
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
-425,000
Closed -$4.3M
SVFAW
239
DELISTED
SVF Investment Corp. Warrant
SVFAW
-50,000
Closed -$1.29K
BRMK.WS
240
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
-7,174,613
Closed -$8.61K
STRE.WS
241
DELISTED
Supernova Partners Acquisition Company III, Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
STRE.WS
-140,000
Closed -$3.22K

Similar funds

Thomas Steyer's Q1 2023 Portfolio in Review

As of Q1 2023, Thomas Steyer held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Thomas Steyer withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in UnitedHealth worth $409M.

  • Thomas Steyer's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Thomas Steyer added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Thomas Steyer's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Thomas Steyer fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Thomas Steyer's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Thomas Steyer opened 14 new positions and closed 63 in Q1 2023.
  • Thomas Steyer's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.